Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

This study has been terminated.
(Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was too slow.)
Sponsor:
Collaborator:
CHUGAI sanofi-aventis
Information provided by (Responsible Party):
European Group for Blood and Marrow Transplantation
ClinicalTrials.gov Identifier:
NCT01163942
First received: July 14, 2010
Last updated: April 2, 2015
Last verified: July 2010